Skip to main content
. 2017 Mar 20;2017:7594805. doi: 10.1155/2017/7594805

Figure 1.

Figure 1

Overview of the workflow for exploring and verifying target biomarkers. In the discovery section, the two groups were randomly divided into two subgroups for biological repetition (EH1, n = 15; EH2, n = 15; TJT1, n = 15; TJT2, n = 15). Then, in verification section, the remaining 17 samples and 13 samples involved in the discovery section were applied in verification.